High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1

BACKGROUND: Expression of programmed-death ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC) is typically evaluated through invasive biopsies; however, recent advances in the identification of circulating tumor cells (CTCs) may be a less invasive method to assay tumor cells for these purposes....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Schehr, Jennifer L., Schultz, Zachery D., Warrick, Jay W., Guckenberger, David J., Pezzi, Hannah M., Sperger, Jamie M., Heninger, Erika, Saeed, Anwaar, Leal, Ticiana, Mattox, Kara, Traynor, Anne M., Campbell, Toby C., Berry, Scott M., Beebe, David J., Lang, Joshua M.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4961410/
https://ncbi.nlm.nih.gov/pubmed/27459545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0159397
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados